Overview

Lung cancer is a condition characterized by uncontrolled cell growth in lung tissues. It is primarily caused by smoking, although non-smokers can develop it too due to factors like secondhand smoke, air pollution, or genetic predisposition. Symptoms may include persistent cough, chest pain, wheezing, and weight loss. Biomarker-based approaches for diagnosis and treatment of lung cancer have revolutionized clinical practice. Biomarkers such as EGFR mutations, ALK rearrangements, and PD-L1 expression are pivotal in guiding treatment decisions, enabling personalized therapies that improve outcomes and minimize side effects. Diagnostic techniques like liquid biopsies offer non-invasive ways to detect these biomarkers, enhancing early detection and monitoring of disease progression. Targeted therapies directed at specific biomarkers have shown remarkable efficacy in subsets of patients, underscoring the importance of molecular profiling in treatment planning. Moreover, immunotherapy agents targeting PD-L1 have expanded treatment options, particularly for advanced stages of the disease. This book provides comprehensive insights into the field of lung cancer diagnosis and treatment. It will also provide interesting topics for research which interested readers can take up. The readers would gain knowledge that would broaden their perspective about lung cancer.

Full Product Details

9781639879953

Table of Contents

Reviews

Author Information

Tab Content 6

Countries Available